Alnylam Pharmaceuticals | Azione

Prezzo Delle Azioni
325.07
Cambio Giornaliero
-7.85 -2.36%
Mensile
-7.60%
Annuale
33.48%
Q1 Previsione
322.73




Azione Cambiamento Data
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
BioCryst Pharmaceuticals USD 5.23M 188K 2025-09
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


Alnylam Pharmaceuticals Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.